510(k) K932127

TDX/TDXFLX & TDXFLX THEOPHYLLINE MONOCLONAL II by Abbott Laboratories — Product Code LGS

K932127 is an FDA 510(k) premarket notification submitted by Abbott Laboratories for the device "TDX/TDXFLX & TDXFLX THEOPHYLLINE MONOCLONAL II". The FDA issued a decision of Substantially Equivalent on August 9, 1993. The device falls under product code LGS (Fluorescence Polarization Immunoassay, Theophylline), a Class II device regulated under 21 CFR 862.3880. Abbott Laboratories has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
August 9, 1993
Date Received
May 3, 1993
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Fluorescence Polarization Immunoassay, Theophylline
Device Class
Class II
Regulation Number
862.3880
Review Panel
TX
Submission Type